Clinical efficacy of an anticolinergic agent in HAM/TPS patients with neurogenic bladder

被引：0
|
作者：
de Castro, Neviton Matos [1 ]
Freitas, Daniel Meira [1 ]
Rodrigues, Waldyr, Jr. [2 ]
Oliveira, Paulo [2 ]
Muniz, Andre [3 ]
de Carvalho, Edgar Marcelino [3 ]
机构：
[1] Univ Fed Bahia, Brazilian Soc Urol, Salvador, BA, Brazil
[2] Univ Fed Bahia, Dept Immunol, Salvador, BA, Brazil
[3] Univ Fed Bahia, Dept Neurol, Salvador, BA, Brazil
来源：
EINSTEIN-SAO PAULO | 2005年 / 3卷 / 04期
关键词：
Human T-lymphotropic virus 1; Paraparesis; tropical spastic; Cholinergic antagonists; Bladder; neurogenic;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: To describe the efficacy of the propantheline bromide in neurogenic bladder in HTLV-I infected patients. Methods: From January/2001 to February/2004, twenty-one HTLV-I-carriers (7 men and 14 women) were selected for treatment with propantheline bromide 15 mg, PO, 2 to 3 times a day for 3 months, not discontinuing in the follow-up. At the end of the treatment period, patients were revaluated through specific questionnaires for urinary symptoms (UDI) and quality of life (Ditrovie). Results: From the 21 patients enrolled, 15 (71.4%) presented important clinical improvement, referring decrease of urinary frequency, urgency and loss, nocturia, and even total control of the dysfunction. Conclusion: We observed an efficient response to the anticholinergic agent propantheline bromide in urinary dysfunction caused by the HTLV-1
引用
收藏
页码：251 / 254
页数：4
相关论文
共 50 条
  • [31] CLINICAL TESTING OF A NOVEL WIRELESS AMBULATORY URODYNAMIC SYSTEM IN PATIENTS WITH NEUROGENIC BLADDER
    Gross, Michael D.
    Lyon, Madison
    Lewis, Kevin
    Elazab, Mohamed
    Tevis, Tyler
    Majerus, Steve
    Hoang-Roberts, Ly
    Damaser, Margot S.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E167 - E168
  • [32] Dosing Variability and Clinical Outcomes of Oxybutynin: A Pediatric Cohort of Patients With Neurogenic Bladder
    Malik, Mahnoor F.
    Randall, Joseph Hogan
    Campbell, Jack G.
    McLaughlin, Matthew J.
    Koenig, Joel F.
    TOPICS IN SPINAL CORD INJURY REHABILITATION, 2022, 28 (03) : 9 - 14
  • [33] Clinical aspects and therapeutic possibilities of neurogenic bladder
    Jaromi Peter
    Banyo Tamas
    Boros Mihaly
    Papp Ferenc
    Szabo Andrea
    ORVOSI HETILAP, 2021, 162 (04) : 135 - 143
  • [34] PARKINSONISM AND NEUROGENIC BLADDER - EXPERIMENTAL AND CLINICAL OBSERVATIONS
    RAZ, S
    UROLOGICAL RESEARCH, 1976, 4 (03): : 133 - 138
  • [35] Clinical aspects and treatment of neurogenic bladder disorders
    Jorg, J
    Haensch, CA
    Schwalen, S
    AKTUELLE NEUROLOGIE, 1998, 25 (05) : 179 - 186
  • [36] STERILE VS CLEAN INTERMITTENT BLADDER CATHETERIZATION: A RANDOMIZED CLINICAL TRIAL IN MYELOMENINGOCELE PATIENTS WITH NEUROGENIC BLADDER
    Madero-Morales, Pedro A.
    Ivan Robles-Torres, J.
    Vizcarra-Mata, Guillermo
    Guillen-Lozoya, Andres H.
    Mendoza-Olazan, Soraya
    Garza-Gonzalez, Elvira
    Gutierrez-Gonzalez, Adrian
    JOURNAL OF UROLOGY, 2019, 201 (04): : E98 - E98
  • [37] Effectiveness of Early Neurogenic Bladder Rehabilitation in Spinal Cord Injured Patients With Neurogenic Overactive Bladder
    Demirel, Fuat
    Demirel, Alev Cevikol
    Umay, Ebru Karaca
    Tuygun, Can
    Topcuoglu, Murat
    Gurcay, Eda
    Cakci, Aytuel
    Altug, Ugur
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2009, 26 (04): : 424 - 431
  • [38] Bladder epithelium is abnormal in patients with neurogenic bladder due to myelomeningocele
    T A Schlager
    R Grady
    S E Mills
    J O Hendley
    Spinal Cord, 2004, 42 : 163 - 168
  • [39] Management of sphincter insufficiency in patients with neurogenic bladder and bladder augmentation
    Taskinen, Seppo
    Makela, Eija
    Pakkasjarvi, Niklas
    PEDIATRIC SURGERY INTERNATIONAL, 2023, 39 (01)
  • [40] Bladder epithelium is abnormal in patients with neurogenic bladder due to myelomeningocele
    Schlager, TA
    Grady, R
    Mills, SE
    Hendley, JO
    SPINAL CORD, 2004, 42 (03) : 163 - 168
12345